Interactions Between HIV and Malaria in African Children

PHASE3CompletedINTERVENTIONAL
Enrollment

351

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
MalariaHIV Infections
Interventions
DRUG

Dihydroartemisinin-piperaquine

Once daily for 3 days, given in fixed dose tablets (40 mg dihydroartemisinin + 320 mg piperaquine) according to weight-based guidelines

DRUG

Artemether-lumefantrine

Dosed twice daily for 3 days, given in fixed dose tablets (20 mg artemether + 120 mg lumefantrine) according to weight-based guidelines

DRUG

Trimethoprim-sulfamethoxazole

Once daily dosing according to weight based guidelines

Trial Locations (1)

Unknown

Tororo District Hospital, Tororo

All Listed Sponsors
collaborator

Centers for Disease Control and Prevention

FED

collaborator

Makerere University

OTHER

collaborator

The AIDS Support Organization

OTHER

lead

University of California, San Francisco

OTHER

NCT00527800 - Interactions Between HIV and Malaria in African Children | Biotech Hunter | Biotech Hunter